COVID-19 second wave won’t be severe but shorter & might fizzle off sooner: Experts
The experts at Neuberg’s Panel discussion on “Coronavirus – variants and vaccination” said there will be the second wave of Coronavirus however it will not be as severe as the first one and it will fizzle off sooner
New Delhi: The experts at Neuberg’s Panel discussion on “Coronavirus – variants and vaccination” said there will be the second wave of Coronavirus however it will not be as severe as the first one and it will fizzle off sooner.
Dr V Ramasubramanian, Infectious Diseases Specialist, Apollo Hospital, said, “US, UK, Brazil and few other countries in Europe had the second wave of Coronavirus. It was inevitable. There is no reason why India would be an exception to this rule. Probably the severity of second would be much milder, because about 60% of our population is younger. The second wave would be far milder than what UK and US are witnessing. We are seeing a surge in several states, but it will not be as severe as first one and would be shorter and fizzle off sooner.”
For a more detailed discussion, watch the video above.
Dr V. Ravi, Former professor of Neurovirology at NIMHAN and Nodal Officer for genomic confirmation of SARS-CoV-2 Government of Karnataka, said, “If you are not infected or not vaccinated, then be sure that the virus will catch you. Sooner or later, the virus will catch most of us.
When there is a huge surge, people behave responsibly. That’s one reason why infection comes down. Whenever, there is a surge, there is continuous, testing, tracking and tracing for containing the infection. Once the first wave subsided, the complacency has set in. Historically, it is true that any respiratory wave will have second wave. So, we will have second wave. But it will not be to the extent of first wave.”
Dr Saranya Narayan, Chief Microbiologist, Neuberg Diagnostics, said, “To certain extent, vaccination will help us in combating the second wave.”
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans